Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
121.9 USD | -1.14% |
|
-1.34% | +27.10% |
Jun. 03 | Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to S&P 1000 | CI |
Jun. 03 | Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to S&P 400 - Biotechnology | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.10% | 11.66B | |
+18.21% | 125B | |
+13.35% | 108B | |
-6.77% | 24.21B | |
+0.73% | 22.78B | |
-11.07% | 17.96B | |
-41.74% | 16.43B | |
-13.61% | 16.37B | |
+1.07% | 13.58B | |
+82.98% | 9.17B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Mizuho Adjusts Price Target on Sarepta Therapeutics to $179 From $145, Maintains Buy Rating